News

Roche to Test Whether New Drug Can Prevent Alzheimer’s
Roche Holding AG plans to test whether an experimental medicine can prevent Alzheimer’s disease symptoms in high-risk people, ...
Roche to test if new drug can prevent Alzheimer’s disease, Bloomberg News reports
(Reuters) -Swiss drugmaker Roche Holding plans to test whether an experimental medicine can prevent Alzheimer's disease ...
Fierce Pharma1d
FDA launches probe into new Elevidys death as Sarepta, Roche stress gene therapy not at fault
In its own communique issued shortly after the FDA’s, Sarepta elaborated on the situation and confirmed a Roche statement to ...
Devdiscourse1d
Roche Investigates Alzheimer's Delaying Drug; Industry Sees Major Moves
Major health news includes Roche's plan to test a drug for Alzheimer's, a US data-sharing initiative in healthcare, Nordic ...
BioSpace20h
Roche’s Next-Gen Alzheimer’s Antibody Clears or Reduces Amyloid Plaques in Seven Months
In a Phase Ib/IIa trial, 91% of patients receiving the highest dose of trontinemab were amyloid negative after seven months of treatment, representing what B. Riley Securities called a “paradigm shift ...
Roche Backs 2025 Views After Strong Sales of Key Drugs
The drugmaker’s sales were up 7% at constant currency from the same period last year.
Fierce Pharma4d
Roche won't throw in the towel after DMD gene therapy Elevidys' rebuff in Europe
Despite a new setback for Elevidys in Europe, Roche—which markets Sarepta’s gene therapy outside the U.S.—remains committed ...
FDA probes death of patient on Sarepta's Elevidys, partner Roche says death unrelated to therapy
The U.S. Food and Drug Administration said on Friday it was investigating the death of an eight-year-old boy who received ...
Roche to investigate whether new drug can delay or prevent Alzheimer’s disease
Swiss drugmaker Roche Holding plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease ...